| Authors: |
Reguzova A; Institute of Immunology, University Hospital Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Müller M; Institute of Immunology, University Hospital Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Pagallies F; Institute of Immunology, University Hospital Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Burri D; Speransa Therapeutics, Bethmannstrasse 8, 60311, Frankfurt am Main, Germany., Salomon F; Institute of Immunology, University Hospital Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Rziha HJ; Institute of Immunology, University Hospital Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Bittner-Schrader Z; Institute of Immunology, University Hospital Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany., Verstrepen BE; Department of Virology, Biomedical Primate Research Centre, Lange Kleiweg 161, 2288GJ, Rijswijk, The Netherlands.; Department of Viroscience, Erasmus University Medical Center, Dr. Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands., Böszörményi KP; Department of Virology, Biomedical Primate Research Centre, Lange Kleiweg 161, 2288GJ, Rijswijk, The Netherlands., Verschoor EJ; Department of Virology, Biomedical Primate Research Centre, Lange Kleiweg 161, 2288GJ, Rijswijk, The Netherlands., Gerhauser I; Department of Pathology, University of Veterinary Medicine Hannover Foundation, Bünteweg 17, 30559, Hannover, Germany., Elbers K; Boehringer Ingelheim International GmbH, Binger Strasse 173, 55216, Ingelheim am Rhein, Germany.; ViraTherapeutics GmbH, Bundesstraße 27, 6063, Rum, Austria., Esen M; Institute of Tropical Medicine, University of Tübingen, Wilhelmstraße 27, 72074, Tübingen, Germany.; German Center for Infection Research (DZIF), Partner Site Tübingen; Cluster of Excellence (EXC2124) 'Controlling Microbes to Fight Infection', Tübingen, Germany., Manenti A; VisMederi Srl., Strada del Petriccio e Belriguardo 35, 53100, Siena, Italy., Monti M; VisMederi Srl., Strada del Petriccio e Belriguardo 35, 53100, Siena, Italy., Rammensee HG; Institute of Immunology, University Hospital Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Derouazi M; Speransa Therapeutics, Bethmannstrasse 8, 60311, Frankfurt am Main, Germany., Löffler MW; Institute of Immunology, University Hospital Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany. markus.loeffler@uni-tuebingen.de.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany. markus.loeffler@uni-tuebingen.de.; Institute for Clinical and Experimental Transfusion Medicine, Medical Faculty of Tübingen, University Hospital Tübingen, Otfried-Müller-Str. 4/1, 72076, Tübingen, Germany. markus.loeffler@uni-tuebingen.de.; Centre for Clinical Transfusion Medicine, Otfried-Müller-Str. 4/1, 72076, Tübingen, Germany. markus.loeffler@uni-tuebingen.de., Amann R; Institute of Immunology, University Hospital Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany. ralf.amann@ifiz.uni-tuebingen.de. |
